WASHINGTON—Daniel Fabricant, Ph.D., resigned as vice president of Global Government and Scientific Affairs for the Natural Products Association (NPA) after five years to enter government service as FDA’s director of its Division of Dietary Supplement Programs. Fabricant will start his new position at the end of February.
Fabricant will transition his responsibilities to Cara Welch, Ph.D., and Liz Hurst who will continue to manage and oversee NPA's collective scientific, regulatory and government affairs portfolio.
“While the decision wasn't an easy one to make," he wrote in an e-mail to industry colleagues, “I am very excited about what lies ahead."
He added, “I am grateful for the opportunities I had at NPA and feel immensely proud of all that has been achieved during my time at the association on the scientific, regulatory and government affairs fronts. I wish the association continued success in the future and want to thank my excellent team for their great work and support."
NPA appointed Fabricant as interim executive director and CEO on Aug. 3, 2010 while the organization looked for a replacement to David Seckman, who headed the association for more than nine years and left to lead the Food Processing Equipment Manufacturers Association. NPA named John F. Gay as the current executive director and CEO in October 2010.
Fabricant previously served as NPA’s vice president of scientific and regulatory affairs. He directed the NPA’s GMP Certification Program, the NPA-U.S. Pharmacopoeia ingredient testing program based in China, and the association's natural certification and TruLabel programs. Additionally, he directed NPA's participation as a subcontractor for the National Institutes of Health's Office of Dietary Supplements Dietary Supplement Label Database (DSLD) feasibility study. He served as a spokesperson for the NPA on scientific, regulatory and technical topics to association members, legislative bodies, regulatory agencies and the media, on the national, international and state level.
Fabricant obtained his doctorate in pharmacognosy at the University of Illinois at Chicago under the renowned professor Norman R. Farnsworth, and he received a bachelor’s of science in chemistry from the University of North Carolina at Chapel Hill.